Expression of CD4~+ CD25~+ regulatory T cells in human bladder carcinoma and its clinical significance

PENG Zi-yuan,JI Zi-liang,ZHANG Qiong-li,DUAN Yong-gang,ZHEN Wan-hua,TANG Ai-fa,CAI Zhi-ming
2013-01-01
Abstract:Objective To investigate the expression of regulatory T cells( Treg cells) in bladder carcinoma and patients' blood and its clinical significance. Methods The tissue and blood samples were collected from patients with bladder cancer( n = 20). T lymphocyte subsets were detected by flow cytometer and cytokines( TGF-β,IL-4,IL- 10,IL-12,IL-17 and IFN-γ) in cancerous and paracancerous tissues were assessed by real-time PCR technology. Clinical pathologic factors were analyzed accordingly. Results A significant increase of the percentage of Treg cells was found in the bladder carcinoma compared with paracancerous tissues [( 29. 10 ± 0. 75) %; P < 0. 01 ],and inhibitory cytokines( TGF-β and IL-10) increased significantly in bladder carcinoma with a rise of IL-17. The percentage of Blood Treg cells increased significantly in carcinoma group compared with normal group but less than that of cancerous tissues in bladder carcinoma[( 15. 68 ± 0. 54) %; P < 0. 01]. Conclusion The overexpression of Treg cells from bladder carcinoma patients indicates an immunosuppressive regulatory profile and the percentage of cancerous Treg cells are associated with the clinical pathologic factors in bladder carcinoma.
What problem does this paper attempt to address?